These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
9. Management of chronic hepatitis C. Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342 [TBL] [Abstract][Full Text] [Related]
10. Natural history of hepatitis C and the impact of anti-viral therapy. Boyer N; Marcellin P Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254 [TBL] [Abstract][Full Text] [Related]
11. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity]. Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470 [TBL] [Abstract][Full Text] [Related]
14. Histological response to interferon alfa-based therapies in hepatitis C. Lee SS Semin Liver Dis; 2004; 24 Suppl 2():55-60. PubMed ID: 15346247 [TBL] [Abstract][Full Text] [Related]
15. [Interferon-alpha and liver fibrosis in patients with chronic damage due to hepatitis C virus]. Gonzalez-Huezo MS; Gallegos-Orozco JF Rev Gastroenterol Mex; 2003; 68(3):239-44. PubMed ID: 14702938 [TBL] [Abstract][Full Text] [Related]
16. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327 [TBL] [Abstract][Full Text] [Related]
17. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490 [TBL] [Abstract][Full Text] [Related]